CDK8 and osteoporosis: Moreover, they showed that pharmacological inhibition of CDK8 represses MSC-dependent osteoclastogenesis and prevents ovariectomy-induced osteoclastic activation and bone loss, highlighting a potential target against osteoporosis with abnormal osteoclastogenesis.